These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20149317)

  • 1. Rheumatoid cachexia and cardiovascular disease.
    Metsios GS; Stavropoulos-Kalinoglou A; Panoulas VF; Sandoo A; Toms TE; Nevill AM; Koutedakis Y; Kitas GD
    Clin Exp Rheumatol; 2009; 27(6):985-8. PubMed ID: 20149317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does Rheumatoid Cachexia Predispose Patients with Rheumatoid Arthritis to Osteoporosis and Vertebral Fractures?
    El Maghraoui A; Sadni S; Rezqi A; Bezza A; Achemlal L; Mounach A
    J Rheumatol; 2015 Sep; 42(9):1556-62. PubMed ID: 26233497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of rheumatoid cachexia assessed by bioelectrical impedance vector analysis and its relation with physical function.
    Santillán-Díaz C; Ramírez-Sánchez N; Espinosa-Morales R; Orea-Tejeda A; Llorente L; Rodríguez-Guevara G; Castillo-Martínez L
    Clin Rheumatol; 2018 Mar; 37(3):607-614. PubMed ID: 29119481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of interleukin-6 (IL-6)-174G/C gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis: the role of obesity and smoking.
    Panoulas VF; Stavropoulos-Kalinoglou A; Metsios GS; Smith JP; Milionis HJ; Douglas KM; Nightingale P; Kitas GD
    Atherosclerosis; 2009 May; 204(1):178-83. PubMed ID: 18848327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients.
    Arts EE; Fransen J; den Broeder AA; Popa CD; van Riel PL
    Ann Rheum Dis; 2015 Jun; 74(6):998-1003. PubMed ID: 24458537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of physical inactivity with increased cardiovascular risk in patients with rheumatoid arthritis.
    Metsios GS; Stavropoulos-Kalinoglou A; Panoulas VF; Wilson M; Nevill AM; Koutedakis Y; Kitas GD
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):188-94. PubMed ID: 19238083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project.
    Castañeda S; Martín-Martínez MA; González-Juanatey C; Llorca J; García-Yébenes MJ; Pérez-Vicente S; Sánchez-Costa JT; Díaz-Gonzalez F; González-Gay MA;
    Semin Arthritis Rheum; 2015 Jun; 44(6):618-26. PubMed ID: 26058345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of rheumatoid arthritis (RA) flare and cumulative burden of RA severity in the risk of cardiovascular disease.
    Myasoedova E; Chandran A; Ilhan B; Major BT; Michet CJ; Matteson EL; Crowson CS
    Ann Rheum Dis; 2016 Mar; 75(3):560-5. PubMed ID: 25637001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cachexia in patients with rheumatoid arthritis: a cohort study.
    Santo RC; Silva JM; Lora PS; Moro ALD; Freitas EC; Bartikoski BJ; Andrade NP; Palominos PE; Hax V; Fighera TM; Spritzer PM; Brenol CV; Chakr RM; Filippin LI; Baker JF; Xavier RM
    Clin Rheumatol; 2020 Dec; 39(12):3603-3613. PubMed ID: 32447598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of serum concentrations of remnant cholesterol with incident cardiovascular disease in patients with rheumatoid arthritis: A real-world data from 2001 to 2022.
    Zou YW; Wu T; Li QH; Ma JD; Pan J; Lu Y; Lin JZ; Jia PW; Zheng HW; Gao JW; Dai W; Mo YQ; Dai J; Dai L
    Int J Cardiol; 2024 Jun; 405():131947. PubMed ID: 38458390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rheumatoid cachexia in early rheumatoid arthritis: prevalence and associated variables.
    Ångström L; Hörnberg K; Sundström B; Södergren A
    Scand J Rheumatol; 2023 Jan; 52(1):10-16. PubMed ID: 34643160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoprotegerin concentrations relate independently to established cardiovascular disease in rheumatoid arthritis.
    López-Mejias R; Ubilla B; Genre F; Corrales A; Hernández JL; Ferraz-Amaro I; Tsang L; Llorca J; Blanco R; González-Juanatey C; Gonzalez-Gay MA; Dessein PH
    J Rheumatol; 2015 Jan; 42(1):39-45. PubMed ID: 25362655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gaps in Addressing Cardiovascular Risk in Rheumatoid Arthritis: Assessing Performance Using Cardiovascular Quality Indicators.
    Barber CE; Esdaile JM; Martin LO; Faris P; Barnabe C; Guo S; Lopatina E; Marshall DA
    J Rheumatol; 2016 Nov; 43(11):1965-1973. PubMed ID: 27481908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of obesity with modifiable risk factors for the development of cardiovascular disease in patients with rheumatoid arthritis.
    Stavropoulos-Kalinoglou A; Metsios GS; Panoulas VF; Douglas KM; Nevill AM; Jamurtas AZ; Kita M; Koutedakis Y; Kitas GD
    Ann Rheum Dis; 2009 Feb; 68(2):242-5. PubMed ID: 18677010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rheumatoid cachexia is associated with dyslipidemia and low levels of atheroprotective natural antibodies against phosphorylcholine but not with dietary fat in patients with rheumatoid arthritis: a cross-sectional study.
    Elkan AC; Håkansson N; Frostegård J; Cederholm T; Hafström I
    Arthritis Res Ther; 2009; 11(2):R37. PubMed ID: 19284557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiorespiratory fitness levels and their association with cardiovascular profile in patients with rheumatoid arthritis: a cross-sectional study.
    Metsios GS; Koutedakis Y; Veldhuijzen van Zanten JJ; Stavropoulos-Kalinoglou A; Vitalis P; Duda JL; Ntoumanis N; Rouse PC; Kitas GD
    Rheumatology (Oxford); 2015 Dec; 54(12):2215-20. PubMed ID: 26209790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study.
    Peters MJ; van Halm VP; Voskuyl AE; Smulders YM; Boers M; Lems WF; Visser M; Stehouwer CD; Dekker JM; Nijpels G; Heine R; Dijkmans BA; Nurmohamed MT
    Arthritis Rheum; 2009 Nov; 61(11):1571-9. PubMed ID: 19877093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome prevalence is increased in rheumatoid arthritis patients and is associated with disease activity.
    da Cunha VR; Brenol CV; Brenol JC; Fuchs SC; Arlindo EM; Melo IM; Machado CA; de Castro Chaves H; Xavier RM
    Scand J Rheumatol; 2012 May; 41(3):186-91. PubMed ID: 22416768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Prevalence of Diastolic Heart Failure in Patients with Rheumatoid Arthritis Correlates with Active Disease, but Not with Treatment Type.
    Schau T; Gottwald M; Arbach O; Seifert M; Schöpp M; Neuß M; Butter C; Zänker M
    J Rheumatol; 2015 Nov; 42(11):2029-37. PubMed ID: 26373561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidants and other novel cardiovascular risk factors in subjects with rheumatoid arthritis in a large population sample.
    De Pablo P; Dietrich T; Karlson EW
    Arthritis Rheum; 2007 Aug; 57(6):953-62. PubMed ID: 17665477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.